Haemonetics
306 hedge funds and large institutions have $4.49B invested in Haemonetics in 2024 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 107 increasing their positions, 112 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
4% less repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 112
3% less funds holding
Funds holding: 317 → 306 (-11)
17% less first-time investments, than exits
New positions opened: 44 | Existing positions closed: 53
Holders
306
Holding in Top 10
3
Calls
$47.1M
Puts
$45M
Top Buyers
| 1 | +$97.6M | |
| 2 | +$42.1M | |
| 3 | +$37.3M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$29.4M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
+$27.8M |
Top Sellers
| 1 | -$200M | |
| 2 | -$60M | |
| 3 | -$20.1M | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$20.1M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$18.1M |